Status:
WITHDRAWN
Adenovirus and Fungal Load in Pediatric Stem Cell Transplant Patients
Lead Sponsor:
Steven B. Kleiboeker
Collaborating Sponsors:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
Adenovirus
Other Mycoses
Eligibility:
All Genders
2-17 years
Brief Summary
This study is designed to determine the rate at which stem cell transplant patients can develop infection caused by a group of viruses, known as adenovirus, and common fungi. Stem cells are unspeciali...
Detailed Description
This study is a multi-center observational study to determine the usefulness of real time PCR in the detection of adenovirus and fungal infections in patients following HSCT. Quantitative viral load m...
Eligibility Criteria
Inclusion
- Pediatric patients greater than or equal to 2 years of age.
- Allogeneic HSCT.
- Willing and able to give signed informed consent, or have a legally authorized representative who is willing to give consent. Informed assent will be required for children \<18 years of age.
- Reliable and willing to make themselves available for the duration of the study.
Exclusion
- Autologous transplant patients are not eligible for the study.
- Patients previously enrolled in the study may not reenroll in the event of a subsequent HSCT.
- Pediatric patients less than 2 years of age are not eligible for the study.
Key Trial Info
Start Date :
March 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2011
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00448994
Start Date
March 1 2007
End Date
July 1 2011
Last Update
December 9 2014
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Mercy Hospital
Kansas City, Missouri, United States, 64108
2
Texas Transplant Institute
San Antonio, Texas, United States, 78229